Insight Molecular Diagnostics Inc banner

Insight Molecular Diagnostics Inc
NASDAQ:IMDX

Watchlist Manager
Insight Molecular Diagnostics Inc Logo
Insight Molecular Diagnostics Inc
NASDAQ:IMDX
Watchlist
Price: 3.21 USD -4.75% Market Closed
Market Cap: $106.4m

Profitability Summary

Insight Molecular Diagnostics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Insight Molecular Diagnostics Inc

Margins Comparison
Insight Molecular Diagnostics Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Insight Molecular Diagnostics Inc
NASDAQ:IMDX
106.4m USD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
364.8B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
183.3B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
172.3B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
109.7B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.4B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
67.6B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.7B EUR
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Insight Molecular Diagnostics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Insight Molecular Diagnostics Inc
NASDAQ:IMDX
106.4m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
364.8B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
183.3B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
172.3B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
109.7B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.4B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
67.6B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.7B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Insight Molecular Diagnostics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett